Skip to content
Lower risk Drug recall · FDA · Published April 24, 2024

SomerSET Therapeutics Haloperidol Injection Recall: Trace Water Risk

SomerSET Therapeutics recalls Haloperidol decanoate injection 50mg/mL vials due to potential trace water contamination. This may cause adverse reactions. Check your vial lot numbers for affected batches.

🇺🇸 FDA recall #D-0506-2024DrugSomerSET Therapeutics ›
Take action

Contact the company

Recalling firmSOMERSET THERAPEUTICS LLC300 Franklin Square Dr · Somerset, NJ 08873-4187
✎ GovInfoNow plain-language explainer

SomerSET Therapeutics is recalling Haloperidol decanoate injections that may contain trace amounts of water for injection. This could lead to adverse reactions if used improperly. Affected vials have specific lot numbers and expiration dates. Read more at govinfonow.com/recall/32710-somerset-therapeutics-haloperidol-injection-recall-trace-water-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/32710-somerset-therapeutics-haloperidol-injection-recall-trace-water-risk · Updated August 17, 2026 · FDA enforcement record: FDA #D-0506-2024

Cite this page

“SomerSET Therapeutics Haloperidol Injection Recall: Trace Water Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32710-somerset-therapeutics-haloperidol-injection-recall-trace-water-risk. Based on FDA recall #D-0506-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0506-2024%22&limit=1).

The FDA announced on April 24, 2024, that Somerset Therapeutics LLC is recalling Haloperidol decanoate Injection due to the presence of a foreign substance. The agency stated the oil-based product may contain trace amounts of water for injection.

How to tell if you have it

  • Brand: SomerSET Therapeutics
  • Product: Haloperidol decanoate Injection 50mg/mL
  • NDC 70069-381-01 (1 mL Single-Dose Vials)
  • NDC 70069-381-10 (10 1mL Single-Dose Vials)
  • Lot #: A230412A, Exp. Date 07/2025
  • Lot #: A230412B, Exp. Date 07/2025

The hazard

According to the FDA, this oil-based product may contain trace amounts of water for injection (WFI). The recall is classified as Class II.

Context

GovInfoNow's records show Somerset Therapeutics LLC has issued four other recalls since June 4, 2020. Other recent recalls include a Dexamethasone Injection recall on February 4, 2026, and a Cisatracurium Besylate Injection recall on November 26, 2025. Similar recent recalls of similar products include an Omnipaque Injection recall on March 24, 2026, and Multrys IV injection and Papaverine HCl Injection recalls on July 24, 2026.

How to tell if you have this one

Check for vials labeled 'Haloperidol decanoate Injection 50mg/mL' with lot numbers A230412A (expiring 07/2025) or A230412B (expiring 07/2025).

  • Brand
    SomerSET Therapeutics
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Vial Lot Numbers

    Identify affected vials by lot numbers A230412A or A230412B with expiration dates of 07/2025.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 35 days after the firm started it.

1. Firm started the recall: Apr 24, 202412. FDA classified it Class II: May 21, 202423. Published in FDA’s Enforcement Report: May 29, 202432024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0506-2024 (April 24, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0506-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA